Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 November 2019 | Story Leonie Bolleurs | Photo Supplied
Bennie
Bennie Botha brings another element of teaching to the classroom for future healthcare professionals. Here, he facilitates a session with students from the School of Nursing.

These days we are surrounded by technology. Interactive whiteboards, 3-D printers, smartphones, laptops, e-books, and virtual reality (VR).

VR was previously associated with the gaming industry, but today it has many uses, including the healthcare industry and more specifically, the field of nursing. 

A staff member in the School of Nursing at the University of the Free State (UFS), Bennie Botha, explains that he always had a fascination with VR. With VR being more affordable to the general user and with him working in the School of Nursing, he wanted to make a difference by providing a more financially sustainable way for students to integrate theory and practical work. 

It was then that Botha, in collaboration with staff from the Department of Computer Science and Informatics and the School of Nursing, developed a virtual environment to train Nursing students as part of his master’s thesis. The title of his dissertation is: Measuring the usability and user experience of virtual reality as a teaching and learning method for nursing students. His supervisor, Dr Lizette de Wet of the Department of Computer Science and Informatics, said the cooperation between two disciplines is important. “This research can make a big contribution towards teaching and learning,” she said. 
 
Adding to existing technology-rich environment

This simulation in a computer-generated environment adds another element to teaching. Instead of only listening to a lecturer, students are immersed in a relevant teaching scenario and are able to interact within a 3D medical institution, treating and taking care of 3D patients. 

The UFS School of Nursing has implemented this first for South Africa, using VR as an instrument to train nursing students. Currently, third-year students and postgraduate Paediatrics students are exposed to this way of training.

This new invention for the School of Nursing adds to the already existing technology-rich environment of the Clinical Simulation Unit within the school; a facility where healthcare students are exposed to training in a safe environment without harming the patient, using high-fidelity patient manikins.

Cost-effective simulation platform

According to Botha, VR provides a cost-effective simulation platform that can be used to augment high-fidelity simulations. “It is also a low-cost alternative for institutions that do not have the capital to implement high-fidelity simulations. By implementing new innovative teaching methods, we aim to provide quality healthcare professionals who can showcase the educational excellence of the School of Nursing at the UFS,” says Botha. 

Rector content

Rector and Vice-Chancellor, Prof Francis Petersen, visited the School of Nursing and engaged in the simulator-based game.
(Photo: Supplied)


He explains the process: “Virtual reality provides students with an opportunity to learn by engaging in a simulator-based game. The virtual environment requires the students to perform a respiratory foreign-body object simulation scenario. Before each virtual simulation session, students are briefed and given the relevant outcomes of the scenario. Students also receive a quick tutorial on the use of the controllers and the head-mounted display.”

“Once a session is complete, a debriefing session is held where students can reflect on the outcome of the simulation. They can view a recording of their own actions for self-reflection afterwards.”

Botha believes the VR environment he created for Nursing students contributes to the Fourth Industrial Revolution, giving the UFS a competitive edge in new developments and the use of innovative teaching and learning technology. 




News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept